BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38280634)

  • 1. Reliability and Variability of Ki-67 Digital Image Analysis Methods for Clinical Diagnostics in Breast Cancer.
    Dawe M; Shi W; Liu TY; Lajkosz K; Shibahara Y; Gopal NEK; Geread R; Mirjahanmardi S; Wei CX; Butt S; Abdalla M; Manolescu S; Liang SB; Chadwick D; Roehrl MHA; McKee TD; Adeoye A; McCready D; Khademi A; Liu FF; Fyles A; Done SJ
    Lab Invest; 2024 May; 104(5):100341. PubMed ID: 38280634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproducibility and Prognostic Potential of Ki-67 Proliferation Index when Comparing Digital-Image Analysis with Standard Semi-Quantitative Evaluation in Breast Cancer.
    Ács B; Madaras L; Kovács KA; Micsik T; Tőkés AM; Győrffy B; Kulka J; Szász AM
    Pathol Oncol Res; 2018 Jan; 24(1):115-127. PubMed ID: 28401450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity and reliability of Ki-67 assessment in oestrogen receptor positive breast cancer.
    Jing N; Fang C; Williams DS
    Pathology; 2017 Jun; 49(4):371-378. PubMed ID: 28450087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue.
    Laurinavicius A; Plancoulaine B; Laurinaviciene A; Herlin P; Meskauskas R; Baltrusaityte I; Besusparis J; Dasevicius D; Elie N; Iqbal Y; Bor C
    Breast Cancer Res; 2014; 16(2):R35. PubMed ID: 24708745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive lobular carcinoma of the breast: assessment of proliferative activity using automated Ki-67 immunostaining.
    Dessauvagie B; Thomas A; Thomas C; Robinson C; Combrink M; Budhavaram V; Kunjuraman B; Meehan K; Sterrett G; Harvey J
    Pathology; 2019 Dec; 51(7):681-687. PubMed ID: 31630876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer.
    Bankhead P; Fernández JA; McArt DG; Boyle DP; Li G; Loughrey MB; Irwin GW; Harkin DP; James JA; McQuaid S; Salto-Tellez M; Hamilton PW
    Lab Invest; 2018 Jan; 98(1):15-26. PubMed ID: 29251737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring.
    Luchini C; Pantanowitz L; Adsay V; Asa SL; Antonini P; Girolami I; Veronese N; Nottegar A; Cingarlini S; Landoni L; Brosens LA; Verschuur AV; Mattiolo P; Pea A; Mafficini A; Milella M; Niazi MK; Gurcan MN; Eccher A; Cree IA; Scarpa A
    Mod Pathol; 2022 Jun; 35(6):712-720. PubMed ID: 35249100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical issues concerning the implementation of Ki-67 proliferative index measurement in breast cancer reporting.
    Harvey J; Thomas C; Wood B; Hardie M; Dessauvagie B; Combrinck M; Frost FA; Sterrett G
    Pathology; 2015 Jan; 47(1):13-20. PubMed ID: 25474507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated imaging analysis of Ki-67 immunohistochemistry on whole slide images of cell blocks from pancreatic neuroendocrine neoplasms.
    Shaker N; Shen R; Limbach AL; Satturwar S; Kobalka P; Ahmadian S; Sun S; Chen W; Lujan G; Esnakula A; Parwani A; Li Z
    J Am Soc Cytopathol; 2024; 13(3):205-212. PubMed ID: 38433072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator study.
    Acs B; Pelekanou V; Bai Y; Martinez-Morilla S; Toki M; Leung SCY; Nielsen TO; Rimm DL
    Lab Invest; 2019 Jan; 99(1):107-117. PubMed ID: 30181553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparison of Visual Assessment and Automated Digital Image Analysis of Ki67 Labeling Index in Breast Cancer.
    Zhong F; Bi R; Yu B; Yang F; Yang W; Shui R
    PLoS One; 2016; 11(2):e0150505. PubMed ID: 26928407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement.
    Koopman T; Buikema HJ; Hollema H; de Bock GH; van der Vegt B
    Breast Cancer Res Treat; 2018 May; 169(1):33-42. PubMed ID: 29349710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital immunohistochemistry wizard: image analysis-assisted stereology tool to produce reference data set for calibration and quality control.
    Plancoulaine B; Laurinaviciene A; Meskauskas R; Baltrusaityte I; Besusparis J; Herlin P; Laurinavicius A
    Diagn Pathol; 2014; 9 Suppl 1(Suppl 1):S8. PubMed ID: 25565221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential immunohistochemistry and virtual image reconstruction using a single slide for quantitative KI67 measurement in breast cancer.
    Serna G; Simonetti S; Fasani R; Pagliuca F; Guardia X; Gallego P; Jimenez J; Peg V; Saura C; Eppenberger-Castori S; Ramon Y Cajal S; Terracciano L; Nuciforo P
    Breast; 2020 Oct; 53():102-110. PubMed ID: 32707454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardization for Ki-67 assessment in moderately differentiated breast cancer. A retrospective analysis of the SAKK 28/12 study.
    Varga Z; Cassoly E; Li Q; Oehlschlegel C; Tapia C; Lehr HA; Klingbiel D; Thürlimann B; Ruhstaller T
    PLoS One; 2015; 10(4):e0123435. PubMed ID: 25885288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Pitfalls in Diagnostic Digital Image Analysis: Experience with Ki-67 and PHH3 in Gastrointestinal Neuroendocrine Tumors.
    Hacking SM; Sajjan S; Lee L; Ziemba Y; Angert M; Yang Y; Jin C; Chavarria H; Kataria N; Jain S; Nasim M
    Pathol Res Pract; 2020 Mar; 216(3):152753. PubMed ID: 31761497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic potential of automated Ki67 evaluation in breast cancer: different hot spot definitions versus true global score.
    Robertson S; Acs B; Lippert M; Hartman J
    Breast Cancer Res Treat; 2020 Aug; 183(1):161-175. PubMed ID: 32572716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ki-67 Proliferation Index Assessment in Gastroenteropancreatic Neuroendocrine Tumors by Digital Image Analysis With Stringent Case and Hotspot Level Concordance Requirements.
    Boukhar SA; Gosse MD; Bellizzi AM; Rajan K D A
    Am J Clin Pathol; 2021 Sep; 156(4):607-619. PubMed ID: 33847759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ki 67 assessment in breast cancer in an Egyptian population: a comparative study between manual assessment on optical microscopy and digital quantitative assessment.
    Ayad E; Soliman A; Anis SE; Salem AB; Hu P; Dong Y
    Diagn Pathol; 2018 Aug; 13(1):63. PubMed ID: 30153851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67.
    Tuominen VJ; Ruotoistenmäki S; Viitanen A; Jumppanen M; Isola J
    Breast Cancer Res; 2010; 12(4):R56. PubMed ID: 20663194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.